Kaplan-Meier Analysis using the Leucegene AML RNA-Seq Prognostic Cohort [n = 373]
The following tool lets you explore the relationship between gene expression and clinical outcome in terms of survival. The cohort is split into 2 categories based on median gene expression value.
The survival cohort consists of 373 diagnostic AML samples (excluding acute promyelocytic leukemia). Gene expression was generated using STAR/RSEM and GRCh38 (Gencode32) and is expressed in TPM.
IMPORTANT: Please note that data displayed below is for informational and educational purposes only. These graphs are from single-variable analyses, meaning that they cannot be used to predict outcomes.